par Stuurman, Frederik;Voest, E.E.;Awada, Ahmad 
;Witteveen, Petronella;Bergeland, T.;Hals, Petter Arnt;Rasch, Wenche;Schellens, Jan J.H.M.;Hendlisz, Alain
Référence Investigational new drugs, 31, 4, page (959-966)
Publication Publié, 2013-08
;Witteveen, Petronella;Bergeland, T.;Hals, Petter Arnt;Rasch, Wenche;Schellens, Jan J.H.M.;Hendlisz, Alain Référence Investigational new drugs, 31, 4, page (959-966)
Publication Publié, 2013-08
Article révisé par les pairs
| Titre: |
|
| Auteur: | Stuurman, Frederik; Voest, E.E.; Awada, Ahmad; Witteveen, Petronella; Bergeland, T.; Hals, Petter Arnt; Rasch, Wenche; Schellens, Jan J.H.M.; Hendlisz, Alain |
| Informations sur la publication: | Investigational new drugs, 31, 4, page (959-966) |
| Statut de publication: | Publié, 2013-08 |
| Sujet CREF: | Cancérologie |
| Pharmacologie | |
| Mots-clés: | Cancer |
| Capsules | |
| CO-1.01 | |
| CP-4126 | |
| dFdC | |
| dFdU | |
| Gemcitabine | |
| Lipid | |
| Oral | |
| Oral administration | |
| Phase 1 | |
| Phospholipids | |
| MeSH keywords: | Administration, Oral |
| Adult | |
| Aged | |
| Antineoplastic Agents -- administration & dosage -- adverse effects -- pharmacokinetics -- therapeutic use | |
| Demography | |
| Deoxycytidine -- administration & dosage -- adverse effects -- analogs & derivatives -- pharmacokinetics -- therapeutic use | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasm Staging | |
| Neoplasms -- drug therapy -- pathology | |
| Note générale: | SCOPUS: ar.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0167-6997 |
| info:doi/10.1007/s10637-013-9925-z | |
| info:scp/84880921868 | |
| info:pmid/23345000 |
